<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16</volume><submitter>Saleem S</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>The aim of this pilot study was to identify proteins associated with advancement of colon cancer (CC).&lt;h4>Methods&lt;/h4>A quantitative proteomics approach was used to determine the global changes in the proteome of primary colon cancer from patients with non-cancer normal colon (NC), non-adenomatous colon polyp (NAP), non-metastatic tumor (CC NM) and metastatic tumor (CC M) tissues, to identify up- and down-regulated proteins. Total protein was extracted from each biopsy, trypsin-digested, iTRAQ-labeled and the resulting peptides separated using strong cation exchange (SCX) and reverse-phase (RP) chromatography on-line to electrospray ionization mass spectrometry (ESI-MS).&lt;h4>Results&lt;/h4>Database searching of the MS/MS data resulted in the identification of 2777 proteins w</pubmed_abstract><journal>Clinical proteomics</journal><pagination>44</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6935225</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Proteomics analysis of colon cancer progression.</pubmed_title><pmcid>PMC6935225</pmcid><pubmed_authors>Atiq A</pubmed_authors><pubmed_authors>Khattak S</pubmed_authors><pubmed_authors>Sadr-Ul Shaheed</pubmed_authors><pubmed_authors>Syed AA</pubmed_authors><pubmed_authors>Ahmad AH</pubmed_authors><pubmed_authors>Sutton C</pubmed_authors><pubmed_authors>Tariq S</pubmed_authors><pubmed_authors>Tahseen M</pubmed_authors><pubmed_authors>Hassan S</pubmed_authors><pubmed_authors>Saleem S</pubmed_authors><pubmed_authors>Yusuf MA</pubmed_authors><pubmed_authors>Abu Bakar M</pubmed_authors><pubmed_authors>Aleem I</pubmed_authors><pubmed_authors>Hussain M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Proteomics analysis of colon cancer progression.</name><description>&lt;h4>Background&lt;/h4>The aim of this pilot study was to identify proteins associated with advancement of colon cancer (CC).&lt;h4>Methods&lt;/h4>A quantitative proteomics approach was used to determine the global changes in the proteome of primary colon cancer from patients with non-cancer normal colon (NC), non-adenomatous colon polyp (NAP), non-metastatic tumor (CC NM) and metastatic tumor (CC M) tissues, to identify up- and down-regulated proteins. Total protein was extracted from each biopsy, trypsin-digested, iTRAQ-labeled and the resulting peptides separated using strong cation exchange (SCX) and reverse-phase (RP) chromatography on-line to electrospray ionization mass spectrometry (ESI-MS).&lt;h4>Results&lt;/h4>Database searching of the MS/MS data resulted in the identification of 2777 proteins w</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019</publication><modification>2026-05-03T07:53:14.689Z</modification><creation>2020-05-22T07:00:36Z</creation></dates><accession>S-EPMC6935225</accession><cross_references><pubmed>31889941</pubmed><doi>10.1186/s12014-019-9264-y</doi></cross_references></HashMap>